These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19517075)

  • 1. Disposable bioreactors: maturation into pharmaceutical glycoprotein manufacturing.
    Brecht R
    Adv Biochem Eng Biotechnol; 2009; 115():1-31. PubMed ID: 19517075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid and disposable facilities for manufacturing of biopharmaceuticals: pros and cons.
    Ravisé A; Cameau E; De Abreu G; Pralong A
    Adv Biochem Eng Biotechnol; 2009; 115():185-219. PubMed ID: 19623478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of disposable bag bioreactors in tissue engineering and for the production of therapeutic agents.
    Eibl R; Eibl D
    Adv Biochem Eng Biotechnol; 2009; 112():183-207. PubMed ID: 19290502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensors in disposable bioreactors status and trends.
    Glindkamp A; Riechers D; Rehbock C; Hitzmann B; Scheper T; Reardon KF
    Adv Biochem Eng Biotechnol; 2009; 115():145-69. PubMed ID: 19475373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study.
    Bareither R; Bargh N; Oakeshott R; Watts K; Pollard D
    Biotechnol Bioeng; 2013 Dec; 110(12):3126-38. PubMed ID: 23775295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposables in downstream processing.
    Gottschalk U
    Adv Biochem Eng Biotechnol; 2009; 115():171-83. PubMed ID: 19373450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bag bioreactor based on wave-induced motion: characteristics and applications.
    Eibl R; Werner S; Eibl D
    Adv Biochem Eng Biotechnol; 2009; 115():55-87. PubMed ID: 19373453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of orbital shaken disposable bioreactors for mammalian cell cultures from the milliliter-scale to the 1,000-liter scale.
    Zhang X; Stettler M; De Sanctis D; Perrone M; Parolini N; Discacciati M; De Jesus M; Hacker D; Quarteroni A; Wurm F
    Adv Biochem Eng Biotechnol; 2009; 115():33-53. PubMed ID: 19499209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.
    Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL
    PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-use disposable technologies for biopharmaceutical manufacturing.
    Shukla AA; Gottschalk U
    Trends Biotechnol; 2013 Mar; 31(3):147-54. PubMed ID: 23178074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology.
    Eibl R; Kaiser S; Lombriser R; Eibl D
    Appl Microbiol Biotechnol; 2010 Mar; 86(1):41-9. PubMed ID: 20094714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technological progresses in monoclonal antibody production systems.
    Rodrigues ME; Costa AR; Henriques M; Azeredo J; Oliveira R
    Biotechnol Prog; 2010; 26(2):332-51. PubMed ID: 20043321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of TAP Ambr 250 disposable bioreactors, as a reliable scale-down model for biologics process development.
    Xu P; Clark C; Ryder T; Sparks C; Zhou J; Wang M; Russell R; Scott C
    Biotechnol Prog; 2017 Mar; 33(2):478-489. PubMed ID: 27977912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposable bioreactors for plant micropropagation and mass plant cell culture.
    Ducos JP; Terrier B; Courtois D
    Adv Biochem Eng Biotechnol; 2009; 115():89-115. PubMed ID: 19475375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Single-Use Bioreactors Used in Modern Liter- and m(3)- Scale Biotechnological Processes: Engineering Characteristics and Scaling Up.
    Löffelholz C; Kaiser SC; Kraume M; Eibl R; Eibl D
    Adv Biochem Eng Biotechnol; 2014; 138():1-44. PubMed ID: 23609177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Konstantinov KB; Cooney CL
    J Pharm Sci; 2015 Mar; 104(3):813-20. PubMed ID: 25417595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upstream processes in antibody production: evaluation of critical parameters.
    Jain E; Kumar A
    Biotechnol Adv; 2008; 26(1):46-72. PubMed ID: 17920803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.